Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that it has received an order from a top 20 global Med Tech leader, an existing customer of Mentice. This order, tailored to meet the client's evolving needs, is for a substantial number of additional Mentice VIST® G7 simulation solutions to complement their existing system fleet. This is the first of three orders related to the same project for systems and software with a total value exceeding 3.2 million USD. All three orders are expected during the second quarter and are related to the Mentice Americas region.

“These three orders represent a significant and continued commitment from this client. Over the past several years, we have been working together to build a global structure and support for the safe roll-out of medical device solutions,” says Göran Malmberg, the CEO of Mentice. “This order, once again, demonstrates the variability of our order intake, while it will significantly contribute to the performance of the second quarter.”


The order will be accounted for in the order book for the business area of the Medical Device Industry during the second quarter of 2024. Most of the products related to these orders will be delivered during the second and third quarters.

Mentice definition of a Top 20 Medical Technology company can be found here: https://www.beckershospitalreview.com/innovation/100-largest-medtech-companies.html.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

This information is information that Mentice is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-05-16 10:30 CEST.

Attachments
Mentice has received a 2.26 million USD order for simulation solutions from a top 20 global MedTech company

© Modular Finance, source Nordic Press Releases